C. Wang

1.1k total citations
24 papers, 820 citations indexed

About

C. Wang is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, C. Wang has authored 24 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in C. Wang's work include Pituitary Gland Disorders and Treatments (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). C. Wang is often cited by papers focused on Pituitary Gland Disorders and Treatments (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). C. Wang collaborates with scholars based in China, Hong Kong and Australia. C. Wang's co-authors include ROSE T. T. YEUNG, Henry Burger, G. C. RENNIE, H.W.G. Baker, Bryan Hudson, K. K. Pun, Karen S.L. Lam, John M. Court, Marjorie Dunlop and D.M. de Kretser and has published in prestigious journals such as The Science of The Total Environment, The Journal of Clinical Endocrinology & Metabolism and Journal of Hazardous Materials.

In The Last Decade

C. Wang

22 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Wang China 12 469 181 176 116 99 24 820
Alpaslan Tuzcu Türkiye 20 425 0.9× 167 0.9× 140 0.8× 143 1.2× 54 0.5× 70 1.1k
J.P. Gutai United States 11 527 1.1× 114 0.6× 120 0.7× 47 0.4× 71 0.7× 18 734
Andrew J. Weissberger Australia 17 1.1k 2.3× 128 0.7× 288 1.6× 96 0.8× 80 0.8× 22 1.3k
Raymond C. Mellinger United States 17 415 0.9× 102 0.6× 176 1.0× 131 1.1× 61 0.6× 51 857
Samuel P. Marynick United States 14 190 0.4× 153 0.8× 232 1.3× 53 0.5× 70 0.7× 23 871
Daniel Ayalon Israel 17 392 0.8× 180 1.0× 122 0.7× 82 0.7× 58 0.6× 64 910
Atilla Büyükgebiz Türkiye 18 430 0.9× 61 0.3× 231 1.3× 119 1.0× 71 0.7× 48 947
H. E. Sjöberg Sweden 15 245 0.5× 53 0.3× 141 0.8× 157 1.4× 100 1.0× 46 759
L. A. Perry United Kingdom 15 471 1.0× 152 0.8× 130 0.7× 201 1.7× 16 0.2× 23 811
María J. Martínez de Osaba Spain 22 314 0.7× 129 0.7× 165 0.9× 208 1.8× 120 1.2× 49 1.2k

Countries citing papers authored by C. Wang

Since Specialization
Citations

This map shows the geographic impact of C. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Wang more than expected).

Fields of papers citing papers by C. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Wang. The network helps show where C. Wang may publish in the future.

Co-authorship network of co-authors of C. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of C. Wang. A scholar is included among the top collaborators of C. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Wang. C. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, C., Ping Li, Bin Liu, et al.. (2025). Molecular mechanisms underlying multi-generational skeletal abnormalities in marine medaka induced by the quinolone antibiotic norfloxacin (NOR). Journal of Hazardous Materials. 496. 139168–139168.
2.
Liu, Bin, et al.. (2025). Developmental toxicity and mechanistic insights of tralopyril in marine medaka: Epigenetic disruptions and ferroptosis. Environmental Chemistry and Ecotoxicology. 7. 1046–1058.
3.
Wang, C., Ping Li, Bin Liu, et al.. (2024). Decrypting the skeletal toxicity of vertebrates caused by environmental pollutants from an evolutionary perspective: From fish to mammals. Environmental Research. 255. 119173–119173. 2 indexed citations
4.
Liu, Bin, C. Wang, Yanan Xu, et al.. (2024). Multigenerational effects of combined exposure of triphenyltin and micro/nanoplastics on marine medaka (Oryzias melastigma): From molecular levels to behavioral response. Journal of Hazardous Materials. 480. 136365–136365. 7 indexed citations
5.
Liu, Bin, et al.. (2023). Long-term tralopyril exposure results in endocrinological and transgenerational toxicity: A two-generation study of marine medaka (Oryzias melastigma). The Science of The Total Environment. 912. 169344–169344. 7 indexed citations
7.
Jing, Haiyan, Jianjie Qin, Mei Feng, et al.. (2010). Nitric oxide in enteric nervous system mediated the inhibitory effect of vasopressin on the contraction of circular muscle strips from colon in male rats. Neurogastroenterology & Motility. 23(3). e125–e135. 8 indexed citations
8.
Kung, Annie W. C., et al.. (1994). Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism. International Journal of Andrology. 17(5). 241–247. 38 indexed citations
9.
Pun, K. K., et al.. (1993). Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement. Osteoporosis International. 3(1). 3–7. 55 indexed citations
10.
Pun, K. K., C. Wang, Patrick Lau, et al.. (1990). Vitamin D status among patients with fractured neck of femur in Hong Kong. Bone. 11(5). 365–368. 39 indexed citations
11.
Kung, Annie W. C., et al.. (1990). Circulating somatostatin after oral glucose in hypothyroidism. Journal of Endocrinological Investigation. 13(5). 403–406. 4 indexed citations
12.
Kung, Annie W. C., Pamela M. Choi, Karen S.L. Lam, et al.. (1990). Discriminant factors affecting early outcome of radioiodine treatment for graves' disease. Clinical Radiology. 42(1). 52–54. 13 indexed citations
13.
Pun, K. K., et al.. (1988). The Use of Glucagon Challenge Tests in the Diagnostic Evaluation of Hypoglycemia due to Hepatoma and Insulinoma*. The Journal of Clinical Endocrinology & Metabolism. 67(3). 546–550. 10 indexed citations
14.
Kung, Annie W. C., C. Wang, K. H. Fu, et al.. (1987). PREVENTION OF HYPOGLYCAEMIA IN A PATIENT WITH PANCREATIC MICROADENOMATOSIS BY A LONG‐ACTING SOMATOSTATIN ANALOGUE SMS 201‐995. Clinical Endocrinology. 27(4). 469–473. 1 indexed citations
15.
Wang, C., et al.. (1987). LONG‐TERM TREATMENT OF HYPERPROLACTINAEMIA WITH BROMOCRIPTINE: EFFECT OF DRUG WITHDRAWAL. Clinical Endocrinology. 27(3). 363–371. 48 indexed citations
16.
Lam, Karen S.L., et al.. (1987). Early Effects of Cranial Irradiation on Hypothalamic-Pituitary Function*. The Journal of Clinical Endocrinology & Metabolism. 64(3). 418–424. 55 indexed citations
17.
Wang, C., et al.. (1986). HYPOTHALAMIC HYPOPITUITARISM FOLLOWING CRANIAL IRRADIATION FOR NASOPHARYNGEAL CARCINOMA. Clinical Endocrinology. 24(6). 643–651. 38 indexed citations
18.
Lam, Karen S.L., et al.. (1986). Hypothalamic defects in two adult patients with septo-optic dysplasia. European Journal of Endocrinology. 112(3). 305–309. 12 indexed citations
19.
Baker, H.W.G., Henry Burger, David M. de Kretser, et al.. (1976). A Study of the Endocrine Manifestations of Hepatic Cirrhosis. QJM. 45(177). 145–78. 165 indexed citations
20.
Baker, H.W.G., Henry Burger, D.M. de Kretser, et al.. (1976). CHANGES IN THE PITUITARY‐TESTICULAR SYSTEM WITH AGE. Clinical Endocrinology. 5(4). 349–372. 248 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026